These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 27876017
1. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility. Rapp J, Kiss E, Meggyes M, Szabo-Meleg E, Feller D, Smuk G, Laszlo T, Sarosi V, Molnar TF, Kvell K, Pongracz JE. BMC Cancer; 2016 Nov 23; 16(1):915. PubMed ID: 27876017 [Abstract] [Full Text] [Related]
2. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. Vesel M, Rapp J, Feller D, Kiss E, Jaromi L, Meggyes M, Miskei G, Duga B, Smuk G, Laszlo T, Karner I, Pongracz JE. Respir Res; 2017 Mar 24; 18(1):52. PubMed ID: 28340578 [Abstract] [Full Text] [Related]
3. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer. Huang CL, Liu D, Nakano J, Ishikawa S, Kontani K, Yokomise H, Ueno M. J Clin Oncol; 2005 Dec 01; 23(34):8765-73. PubMed ID: 16314637 [Abstract] [Full Text] [Related]
4. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LM. J Clin Oncol; 2012 Apr 01; 30(10):1129-36. PubMed ID: 22355056 [Abstract] [Full Text] [Related]
5. Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinoma. Bartis D, Csongei V, Weich A, Kiss E, Barko S, Kovacs T, Avdicevic M, D'Souza VK, Rapp J, Kvell K, Jakab L, Nyitrai M, Molnar TF, Thickett DR, Laszlo T, Pongracz JE. PLoS One; 2013 Apr 01; 8(3):e57393. PubMed ID: 23505429 [Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma. Ozbudak IH, Ozbilim G, Kucukosmanoglu I, Dertsiz L, Demircan A. Int J Surg Pathol; 2009 Oct 01; 17(5):390-5. PubMed ID: 18849317 [Abstract] [Full Text] [Related]
9. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. Chen J, Liu A, Wang Z, Wang B, Chai X, Lu W, Cao T, Li R, Wu M, Lu Z, Pang W, Xiao L, Chen X, Zheng Y, Chen Q, Zeng J, Li J, Zhang X, Ren D, Huang Y. Mol Cancer; 2020 May 30; 19(1):98. PubMed ID: 32473645 [Abstract] [Full Text] [Related]
10. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y. Eur J Cancer; 2014 Sep 30; 50(13):2336-50. PubMed ID: 25001183 [Abstract] [Full Text] [Related]
11. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y, Li S, Li J, Wang D, Li Q. Cell Physiol Biochem; 2017 Sep 30; 42(4):1431-1446. PubMed ID: 28715819 [Abstract] [Full Text] [Related]
12. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC). Mao Z, Xu B, He L, Zhang G. Med Sci Monit; 2019 Jul 21; 25():5418-5425. PubMed ID: 31326971 [Abstract] [Full Text] [Related]
14. Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis. Korde A, Jin L, Zhang JG, Ramaswamy A, Hu B, Kolahian S, Guardela BJ, Herazo-Maya J, Siegfried JM, Stabile L, Pisani MA, Herbst RS, Kaminski N, Elias JA, Puchalski JT, Takyar SS. Am J Respir Crit Care Med; 2017 Dec 01; 196(11):1443-1455. PubMed ID: 28853613 [Abstract] [Full Text] [Related]
15. CircVAPA exerts oncogenic property in non-small cell lung cancer by the miR-876-5p/WNT5A axis. Zhao Y, Dai Q, Fu X, Chen Q, Tang Y, Gao X, Zhou Q. J Gene Med; 2021 Jun 01; 23(6):e3325. PubMed ID: 33619796 [Abstract] [Full Text] [Related]
16. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer. Azuma K, Kawahara A, Hattori S, Taira T, Tsurutani J, Watari K, Shibata T, Murakami Y, Takamori S, Ono M, Izumi H, Kage M, Yanagawa T, Nakagawa K, Hoshino T, Kuwano M. J Thorac Oncol; 2012 May 01; 7(5):779-89. PubMed ID: 22481237 [Abstract] [Full Text] [Related]
18. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations. Boldrini L, Gisfredi S, Ursino S, Lucchi M, Mussi A, Basolo F, Pingitore R, Fontanini G. Lung Cancer; 2005 Dec 01; 50(3):309-17. PubMed ID: 16125276 [Abstract] [Full Text] [Related]
19. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. Maeda R, Ishii G, Ito M, Hishida T, Yoshida J, Nishimura M, Haga H, Nagai K, Ochiai A. J Thorac Oncol; 2012 Mar 01; 7(3):503-11. PubMed ID: 22198428 [Abstract] [Full Text] [Related]
20. Targeting angiogenesis in squamous non-small cell lung cancer. Piperdi B, Merla A, Perez-Soler R. Drugs; 2014 Mar 01; 74(4):403-13. PubMed ID: 24578213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]